Melanoma cells can express some inhibitory molecules, such as Programmed cell death 1 ligand 1 (PD-L1) and Cytotoxic T-lymphocyte protein 4 (CTLA-4), to block T-cell activation and function activities [40,41]. The gene discussed is CTLA4; the disease is melanoma.